Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03445858
Title Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

Advanced Solid Tumor

lymphoma

Therapies

Decitabine + Pembrolizumab

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.